59.00

3.01% -1.83

After Hours: 59.00

Disc Medicine Inc (IRON)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Disc Medicine Inc stock is traded at $59.00, with a volume of 407.27K. It is down -3.01% in the last 24 hours and up +7.76% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Previous Close:

$60.83

Open:

$60.32

24h Volume:

407.27K

Relative Volume:

1.09

Market Cap:

$2.04B

Revenue:

Net Income/Loss:

$-91.00M

P/E Ratio:

-16.08

EPS:

-3.67

Net Cash Flow:

$-74.38M

1W Performance:

-0.59%

1M Performance:

+7.76%

6M Performance:

+4.81%

1Y Performance:

+40.11%

1-Day Range:

$57.77

$60.35

1-Week Range:

$57.77

$60.95

52-Week Range:

$30.82

$68.73

Disc Medicine Inc Stock (IRON) Company Profile

Name

Disc Medicine Inc

Sector

Healthcare (1161)

Industry

Biotechnology (647)

Phone

(617) 674-9274

Address

321 ARSENAL STREET, SUITE 101, WATERTOWN

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

IRON's Discussions on Twitter

Compare IRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRON Disc Medicine Inc	59.00	2.11B	0	-91.00M	-74.38M	-3.67
VRTX Vertex Pharmaceuticals Inc	385.65	96.11B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	555.13	60.40B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	428.14	54.91B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	673.15	41.30B	3.05B	1.28B	-614.78M	19.58
ONC Beone Medicines Ltd Adr	298.52	33.25B	3.81B	-644.79M	-669.77M	-6.24

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-25	Initiated	Truist	Buy
Jul-03-25	Resumed	Morgan Stanley	Overweight
Jun-11-25	Resumed	Raymond James	Strong Buy
Feb-27-25	Initiated	TD Cowen	Buy
Nov-05-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-04-24	Upgrade	Raymond James	Outperform → Strong Buy
Oct-23-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy
Jun-07-23	Initiated	H.C. Wainwright	Buy
May-17-23	Initiated	Raymond James	Outperform
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight
Apr-21-23	Initiated	Stifel	Buy
Apr-20-23	Initiated	Morgan Stanley	Overweight
Mar-23-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Disc Medicine Inc Stock (IRON) Latest News

Aug 04, 2025

How strong is Disc Medicine Inc. company’s balance sheetInvest confidently with real-time market updates - Jammu Links News

Aug 04, 2025

Aug 03, 2025

Is Disc Medicine Inc. a good long term investmentDiscover dynamic stocks ready to soar - Jammu Links News

Aug 03, 2025

Is it the right time to buy Disc Medicine Inc. stockMarket-leading growth rates - Jammu Links News

Aug 03, 2025

What catalysts could drive Disc Medicine Inc. stock higher in 2025Achieve consistent double-digit growth - Jammu Links News

Aug 03, 2025

What analysts say about Disc Medicine Inc. stockMaximize portfolio growth with professional advice - Jammu Links News

Aug 03, 2025

Is Disc Medicine Inc. a growth stock or a value stockMarket-beating performance - Jammu Links News

Aug 03, 2025

Published on: 2025-08-03 11:24:58 - Jammu Links News

Aug 03, 2025

What are analysts’ price targets for Disc Medicine Inc. in the next 12 monthsBuild a winning investment strategy today - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How many analysts rate Disc Medicine Inc. as a “Buy”Realize exceptional returns through smart trading - Jammu Links News

Aug 02, 2025

How does Disc Medicine Inc. generate profit in a changing economyHigh-octane investment opportunities await - Jammu Links News

Aug 02, 2025

Insider Selling at Disc Medicine Inc.: A Signal or a Symptom? - AInvest

Aug 02, 2025

Aug 01, 2025

Is Disc Medicine Inc. stock overvalued or undervaluedLow Risk Report For Consistent Profits - Jammu Links News

Aug 01, 2025

Jul 30, 2025

Institutional Investors in Disc Medicine, Inc. (NASDAQ:IRON) See US$140m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛

Jul 30, 2025

Why Disc Medicine Inc. stock attracts strong analyst attentionNews Based Entry Opportunity Alerts Detected - metal.it

Jul 30, 2025

Jul 29, 2025

Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT - MSN

Jul 29, 2025

How does Disc Medicine Inc. compare to its industry peersExpert Picks Watchlist For 2025 - Jammu Links News

Jul 29, 2025

Jul 28, 2025

Disc Medicine's NDA Submission for Bitopertin in EPP: A High-Probability Catalyst for Value Creation - AInvest

Jul 28, 2025